Literature DB >> 31243351

The relationship between erectile dysfunction and the Atherogenic Index of Plasma.

Emrah Ermis1, Sinem Ozbay Ozyilmaz2, Emre Salabas3, Cem Senol4, Mahir Cengiz5, Samir Allahverdiyev2, Hakan Ucar2.   

Abstract

The objective of this study was to compare the Atherogenic Index of Plasma (AIP) values as indicators of subclinical atherosclerosis among 124 patients with erectile dysfunction, which was thought to be vasculogenic and 126 control subjects who had no erectile dysfunction, and to compare cardiac performance values between both the groups using exercise stress tests (EST). Erectile function was assessed using the International Index of Erectile Function (IIEF-5) questionnaire form. AIP values were studied and compared between patients with ED (IIEF  <  22) and those without ED (IIEF  >  22) using the log10 TG/HDL-C formula. In addition, the correlation between the severity of ED and AIP was investigated according to IIEF-5 scoring. Metabolic equivalent (MET) values, maximal heart rates (max HR), and heart rate recovery (HRR) were evaluated with effort tests. AIP values were significantly higher in the ED group than in the control group (0.45  ±  0.27, and 0.37  ±  0.27; p  =  0.015). According to IIEF-5 scoring, AIP values increased as ED scores decreased. In the EST, MET score and max HR values were significantly lower in the ED group (METs: 11.1  ±  2.2, and 11.6  ±  2.2; p  =  0.045; Max HR: 162.8  ±  6.1, and 165  ±  8.7; p  =  0.019). Although not statistically significant, HRR values were lower in the ED group. Higher AIP values were found in the ED group, and a positive correlation was established between AIP and the severity of ED. In addition, lower performance during the EST and lower HRR values, again in the ED group, confirms cardiac interaction with ED. These results indicate the importance of referral of patients with ED from urology clinics to cardiology units for risk determination and cardiac assessment, even if they areasymptomatic.

Entities:  

Mesh:

Year:  2019        PMID: 31243351     DOI: 10.1038/s41443-019-0167-2

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  5 in total

1.  Association of uric acid, atherogenic index of plasma and albuminuria in diabetes mellitus.

Authors:  Emin Murat Akbas; Aysu Timuroglu; Adalet Ozcicek; Fatih Ozcicek; Levent Demirtas; Adem Gungor; Nergis Akbas
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Atherogenic index of plasma as a cardiovascular risk marker in manic, depressive, and euthymic stages of bipolar disorder.

Authors:  Tevfik Kalelioğlu; Pelin Ünalan; Burcu Kök; Şule Sözen; Özge Yüksel; Mustafa Akkuş; Refik Cihnioğlu; Nesrin Karamustafalıoğlu
Journal:  Turk Kardiyol Dern Ars       Date:  2018-01

Review 3.  [AIP--atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice].

Authors:  M Dobiásová
Journal:  Vnitr Lek       Date:  2006-01

4.  Diagnosis and treatment of erectile dysfunction--a practical update.

Authors:  C Persu; V Cauni; S Gutue; Elena Simona Albu; V Jinga; P Geavlete
Journal:  J Med Life       Date:  2009 Oct-Dec

5.  Atherogenic Index of Plasma (AIP): A marker of cardiovascular disease.

Authors:  Shabnam Niroumand; Mohammad Khajedaluee; Majid Khadem-Rezaiyan; Maryam Abrishami; Mohammadreza Juya; Gholamhasan Khodaee; Maliheh Dadgarmoghaddam
Journal:  Med J Islam Repub Iran       Date:  2015-07-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.